Watch Falcon 9 launch 25 @Starlink satellites to orbit from California https://t.co/TZv6mGeYcw ...

Nothing says “Friday afternoon in Washington” quite like a constitutional crisis followed by a spontaneous tax on every single thing you own. On February 20, 2026, the U.S. Supreme Court decided to remind the executive branch that the International Emergency Economic Powers Act (IEEPA) isn’t actually a “do whatever you want” card. In a 6-3 ruling that left the White House fuming and trade lawyers salivating, the Court struck down President Donald Trump’s sweeping reciprocal tariffs as unlawful. Naturally, t ...

Core Viewpoint - Airbus SE is a prominent aerospace corporation engaged in commercial aircraft, defense, and space sectors, facing competition from Boeing. The company is currently navigating challenges in the Future Combat Air System (FCAS) project while maintaining a strong market presence [1][2][4]. Group 1: Stock Performance - As of the latest trading session, EADSY is priced at $55.84, reflecting a 1.62% increase or $0.89 from the previous price [3]. - The stock has experienced significant volatility over the past year, with a high of $64.35 and a low of $36.28 [3]. - Jefferies has maintained a "Hold" rating for EADSY, adjusting the price target from EUR 215 to EUR 195 [1]. Group 2: Market Position and Projects - Airbus's market capitalization stands at approximately $175.84 billion, indicating its substantial role in the aerospace industry [4]. - The company is actively involved in the FCAS project, a collaboration among France, Germany, and Spain, and is prepared to adapt to potential changes in the project structure [2]. - Airbus's CEO has expressed confidence in the company's capability to independently develop a fighter jet if required [2]. Group 3: Trading Activity - The trading volume for EADSY is recorded at 23,021 shares on the OTC exchange, suggesting moderate investor interest [4].

Article contentThe numbers in Canada’s just-announced defence industrial strategy are big: $180 billion in procurement and $290 billion in defence capital investment, spread out over 10 years, with Prime Minister Mark Carney pledging the strategy will prioritize the awarding of contracts to Canadian companies. “Our initial reaction is that the announced initiatives are highly constructive for our coverage, given the strong ‘Buy Canada’ focus, the targeted sectors/capabilities (in our coverage’s wheelhouse), ...

Core Viewpoint - Boeing's CST-100 Starliner faced criticism in a recent NASA report, highlighting ongoing challenges for the company in its space endeavors and implications for its stock performance [1]. Group 1: NASA Report Findings - NASA released a report detailing the failed crewed flight test of the CST-100 Starliner, emphasizing the need for significant improvements in Boeing's operations [1]. - The report serves as a reminder of the challenges Boeing faces in the commercial space sector, which could impact investor confidence [1]. Group 2: Implications for Boeing - The ongoing issues with the Starliner program may necessitate changes within Boeing to enhance its performance and restore investor trust [1]. - Investors are advised to consider how these developments could affect Boeing's stock market performance moving forward [1].

Transport Canada has certified Gulfstream G500 and G600 jets, document says | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A Gulfstream Aerospace G500 aircraft arrives at the 54th International Paris Airshow at Le Bourget Airport near Paris, France, June 18, 2023. REUTERS/Benoit Tessier [Purchase Licensing Rights, opens new tab]MONTREAL, Feb 20 (Reuters) - Transport Canada has certified General Dynamics [(GD.N), opens new tab] Gul ...

ED: WELCOME TO "BLOOMBERG TECH," IN THE LAST HOUR THE U.S. SUPREME COURT HAS STRUCK DOWN PRESIDENT TRUMP'S SWEEPING GLOBAL TARIFFS. BLOOMBERG IS REPORTING THAT THE PRESIDENT HAS A BACKUP PLAN AND HAS LABELED THE DECISION A DISGRACE. WE WILL GET TO MARKETS AND SUMMARIZE THE REACTION.EQUITIES SURGED, PARTICULARLY TECHNOLOGY STOCKS. THE NASDAQ 100 AND THE PHILADELPHIA SEMICONDUCTOR INDEX CONTINUE TO PUSH TO SESSION HIGHS. BONDS FELL, THE DOLLAR FELL, PARTICULARLY 10 YEAR YIELD UP TO BASIS POINTS AT 4.09%.30 YE ...

Elon Musk: "We will be back on the Moon soon, permanently this time" https://t.co/gHLWZvh6KrTesla Owners Silicon Valley (@teslaownersSV):BREAKING: Elon Musk confirms Starship will launch over 10,000 Starlink satellites per year. 🚀Scale is about to increase dramatically. https://t.co/a3vVgotiFD ...

Core Insights - Astronics Corporation (ATRO) is expected to report improved earnings for the fourth quarter of 2025, with a consensus estimate of 60 cents per share, reflecting a 25% year-over-year increase [1][5] Earnings Estimates - The current earnings estimate for Q4 2025 is 60 cents, unchanged from the previous week, with a notable increase from 57 cents 30 days ago [2] - The average earnings surprise over the last four quarters has been 59.10%, indicating a strong track record of exceeding estimates [2] Earnings Prediction Model - The Zacks model indicates a likely earnings beat for Astronics, supported by a positive Earnings ESP of +10.61% and a Zacks Rank of 2 (Buy) [3][4] Revenue Projections - Astronics projects Q4 revenues between $225 million and $235 million, driven by strong sales in the Commercial Transport and Military Aircraft segments [5][6] - Increased demand for cabin power and safety products is expected to enhance revenue growth, with backlog also anticipated to rise [6] Margin and Expense Management - The company is likely to benefit from decreased interest expenses due to refinancing and reduced R&D costs, contributing to margin expansion [7] - Improved productivity and pricing initiatives in the Aerospace segment are expected to support operating margin growth [7] Stock Performance and Valuation - Astronics' stock has outperformed the industry, sector, and S&P 500 in Q4 2025, currently trading at a price-to-sales multiple of 2.87, significantly lower than the industry average of 12.73 [8][9] - The stock is considered attractively valued compared to peers like Kratos Defense & Security Solutions and Rocket Lab USA, Inc [10] Investment Thesis - The company is well-positioned to benefit from strong demand in both defense and commercial aerospace markets, supported by increased global defense spending and airline modernization efforts [11] - Management is focused on margin enhancement through cost control and disciplined capital deployment, with a strong backlog providing revenue visibility [12] Challenges - Supply-chain constraints, including raw material shortages and labor scarcity, pose challenges, along with potential impacts from increased U.S. tariffs [13] Strategic Outlook - Astronics is expected to leverage its niche focus and proprietary technologies to capitalize on aerospace growth trends, supported by optimistic analyst sentiment and favorable valuation metrics [16]

Market Overview - Gold prices have surpassed $5,000 per ounce, indicating a significant increase in value [1] - The White House has allocated $12 billion for critical mineral stockpiling, reflecting a strategic move towards resource security [2] - The FDA approved over 50 oncology treatments in 2025, showcasing rapid advancements in the healthcare sector [3] Company Highlights - **VisionWave Holdings (NASDAQ: VWAV)**: The company is developing an AI-controlled intelligent radar system with a distributed mesh decoy architecture, which could enhance operational efficiency compared to traditional radar systems [3][4] - **Starfighters Space (NYSE-A: FJET)**: The company is progressing to the Critical Design Review for STARLAUNCH 1, supported by GE Aerospace. This follows successful wind tunnel tests at speeds of Mach 0.85 and Mach 1.3 [5][6] - **Ares Strategic Mining (CSE: ARS / OTCQX: ARSMF)**: Ares holds the only permitted domestic source of fluorspar in the U.S. and has secured a $168.9 million contract with the Pentagon, with potential task orders reaching $250 million [6][7] - **Lake Victoria Gold (TSXV: LVG / OTCQB: LVGLF)**: The company reported drilling results confirming mineralization at its Imwelo Gold Project, with notable gold grades of 11.88 g/t over 1.33m and continuity extending beyond historical limits [8][9] - **Oncolytics Biotech (NASDAQ: ONCY)**: The company received FDA Fast Track Designation for its treatment in colorectal cancer, showing a 33% response rate compared to ~10% with standard chemotherapy, significantly improving patient outcomes [10][11]